Trial NCT03784599

View at ClinicalTrials.gov 
Org. Study IDs: M18TEO

Last trial update was posted on 2022-11-10

MeSH Interventions

Ado-Trastuzumab Emtansine Maytansine Osimertinib Trastuzumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions


Stopping Reasons

insufficient effectiveness

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID